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T.L. Forbes, Associate Editor, Journal of Vascular Surgery
Division of Vascular Surgery, University of Toronto, Toronto, ON, CanadaNotwithstanding the headline debate about whether an
“endovascular ﬁrst” or an “open surgery ﬁrst” strategy is
preferable or safer, the most important issue raised by our
debaters (and one which should concern all of us) is that a
diagnosis of acute mesenteric ischemia (AMI) is still
invariably delayed and usually only considered once the
patient has become too ill to undergo any form of mean-
ingful intervention. The data from the US National Inpatient
Sample, which showed that only 15% of patients with AMI
were actually treated and that only 3% had the chance to
beneﬁt from endovascular or open revascularization, makes
extremely depressing reading. Put another way: almost nine
out of every 10 patients with a diagnosis of suspected AMI
will undergo no active treatment. Such bleak statistics de-
mand that medical professionals (of all disciplines) be made
more aware of the importance of at least considering a
diagnosis of AMI in patients.
Returning to the “meat” of the debate, the contributors
have provided positive and negative data regarding their
respective positions. That is not surprising, given the nature
of a debate. We suspect, however, that a signiﬁcant pro-
portion of our surgical readers will rarely (or never) consider
an “endovascular ﬁrst” strategy for the treatment of patients
with AMI (unlike patients with chronic mesenteric ischemia),
largely because of an intuitively held belief (espoused by Drs.
Orr and Endean) that endovascular strategies have little to
offer in these acute, life-threatening situations, and that
emergency laparotomy is mandatory in order to gauge theseverity of ischemia, enable revascularization, and allow the
resection of compromised bowel before it worsens and
precipitates multiorgan failure. However, Martin Björck has
also shown that surgeons may have been wrong to uncriti-
cally dismiss a role for an “endovascular ﬁrst” strategy. This is
supported by international registries reporting that up to
50% of contemporary arterial revascularizations for AMI now
follow an “endovascular ﬁrst” strategy, with bailout surgical
bypass being possible in up to half of those cases where an
endovascular intervention failed to recanalize the superior
mesenteric artery. One would not expect to have observed
such an increase in the proportion of interventional thera-
pies if an “endovascular ﬁrst” strategy was associated with
poorer outcomes compared with the traditional open sur-
gical approach.
There are obvious advantages to either strategy. Endo-
vascular therapy is less invasive, can be done under local
anesthesia, avoids a major laparotomy in compromised in-
dividuals, and (perhaps most importantly) ﬁnishes with
completion angiography in order to identify and treat re-
sidual thrombus/defects, thereby optimizing the overall
quality of the revascularization. The “Achilles’ heel” of an
“endovascular ﬁrst” strategy, however, is determining exactly
when someone needs a second-look laparotomy to identify
the patient with persisting focal bowel ischemia before it
perforates. Martin Björck advocates a liberal approach to
second-look laparotomy, but it is not always apparent when
one is required. The “open surgery ﬁrst” approach, as stated
280 Trans-Atlantic Debateby Drs. Orr and Endean, is more generalizable and does not
require complex endovascular skills that may not be avail-
able in most hospitals. This type of patient is usually too ill to
transfer to another, more experienced endovascular institu-
tion, usually because of the delay in diagnosis.
As with most issues in medicine, a “one size ﬁts all”
strategy rarely works and it is inevitable that endovascular
and open surgery will evolve complementary roles in the
management of AMI. This will be particularly true in the era
of hybrid endovascular theatres where the patient canundergo any combination of the two approaches, as well as
laparoscopy. Moreover, the addition of open retrograde
SMA angioplasty and/or stenting will increase revasculari-
zation options, while at the same time permitting the sur-
geon to inspect the bowel for areas of doubtful viability.
However, any meaningful debate about whether an
“endovascular ﬁrst” or an “open surgery ﬁrst” strategy is
safer in patients with AMI is pointless unless the medical
profession becomes much better at diagnosing AMI early.
That remains the most important challenge facing all of us.*Corresponding author.
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